Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24251361 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Clarification of Optimal Anticoagulation Through Genetics
Conditions: Stroke;   Venous Thrombosis;   Atrial Fibrillation;   Atrial Flutter
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Clinical-guided dosing algorithm for warfarin

Indicates status has not been verified in more than two years